Advertisement

Natural History: Importance of Size, Site, Histopathology

  • Murray F. Brennan
  • Cristina R. Antonescu
  • Kaled M. Alektiar
  • Robert G. Maki
Chapter

Abstract

The natural history of soft tissue sarcoma is highly influenced by the site of the primary lesion, tumor histopathology, and tumor size. Multiple approaches have been developed to define outcome variables based on these factors, and as data accumulate with sufficient numbers, progressively more refined staging or predictive systems can be provided for rare tumors with multiple variables.

Keywords

Natural history Outcome predictions Local recurrence Disease-free survival Overall survival Nomogram Endpoint Bayesian belief model Staging system AJCC, American Joint Committee on Cancer 

References

  1. 1.
    Geer RJ, Woodruff J, Casper ES, et al. Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg. 1992;127:1285–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Grosso F, Sanfilippo R, Virdis E, et al. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol. 2009;20:1439–44.CrossRefPubMedGoogle Scholar
  3. 3.
    De Wever I, Dal Cin P, Fletcher CD, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Chromosomes and morphology. Mod Pathol. 2000;13:1080–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Wunder JS, Healey JH, Davis AM, et al. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer. 2000;88:2721–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Wolf RE, Enneking WF. The staging and surgery of musculoskeletal neoplasms. Orthop Clin North Am. 1996;27:473–81.PubMedGoogle Scholar
  6. 6.
    Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355–65.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Pisters PW, Leung DH, Woodruff J, et al. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679–89.PubMedGoogle Scholar
  8. 8.
    Eilber FC, Brennan MF, Riedel E, et al. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas. Ann Surg Oncol. 2005;12:228–36.CrossRefPubMedGoogle Scholar
  9. 9.
    Maki RG, Moraco N, Antonescu CR, et al. Toward better soft tissue sarcoma staging: building on American Joint Committee on Cancer Staging Systems versions 6 and 7. Ann Surg Oncol. 2013;20:3377–83.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Eilber FC, Brennan MF, Eilber FR, et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004;101:2270–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103:402–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–91.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med. 2003;22:3515–25.CrossRefPubMedGoogle Scholar
  15. 15.
    Cahlon O, Brennan MF, Jia X, et al. A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Ann Surg. 2012;255:343–7.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zivanovic O, Jacks LM, Iasonos A, et al. A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma. Cancer. 2012;118:660–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Crago AM, Denton B, Salas S, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258:347–53.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Canter RJ, Qin LX, Maki RG, et al. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. 2008;14:8191–7.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Forsberg JA, Healey JH, Brennan MF. A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network. Ann Surg Oncol. 2012;19:2992–3001.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Murray F. Brennan
    • 1
  • Cristina R. Antonescu
    • 2
  • Kaled M. Alektiar
    • 3
  • Robert G. Maki
    • 4
  1. 1.International Center Department of SurgeryMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Department of PathologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  3. 3.Department of Radiation OncologyMemorial Sloan Kettering Cancer CenterNew YorkUSA
  4. 4.Monter Cancer CenterHofstra Northwell School of Medicine and Cold Spring Harbor LaboratoryLake SuccessUSA

Personalised recommendations